Related Experiment Video
Updated: Jan 14, 2026
Measuring Cardiac Autonomic Nervous System ANS Activity in Children
Published on: April 29, 2013
Establishing normative data for EpiTrack Junior in Danish pediatric population - an international comparison
Angelique J Ohlsen1, Camilla B Sørensen1, Theis Lange2
1Department of Pediatrics and Adolescent Medicine, Herlev and Gentofte University Hospital, Herlev, Denmark.
Insights
The EpiTrack Junior cognitive screening tool showed lower scores in Danish children compared to German children. A revised age-correction is suggested for the Danish pediatric population to improve accuracy.
Area of Science:
- Neuropsychology
- Pediatric Neurology
Background:
- Epilepsy in children can lead to cognitive impairments.
- EpiTrack Junior is a screening tool for attention and executive functions in children with epilepsy.
Purpose of the Study:
- Establish normative data for Danish children using EpiTrack Junior.
- Compare Danish and German pediatric norm samples.
- Develop a revised age-correction for Danish children.
Main Methods:
- EpiTrack Junior administered individually (12-15 min).
- Six subtests derived from the adult version.
- 346 healthy Danish children aged 6-18 years tested.
Main Results:
- Danish sample had more scores in 'mildly impaired' and 'significantly impaired' categories than the German sample.
- Younger children (≤12 years) showed declining scores with age; older children (≥13 years) showed stable scores.
- A revised age-correction for the Danish pediatric population was proposed.
Conclusions:
- Danish children scored significantly lower than German controls on EpiTrack Junior.
- Normative data is crucial for adapting tests like EpiTrack Junior to specific populations.
Objective:
Children diagnosed with epilepsy can experience cognitive impairment. EpiTrack Junior is a time-efficient screening tool designed to assess attention and executive functions in children diagnosed with epilepsy. This study aims to establish normative data for Danish children, to investigate differences between the Danish and German pediatric norm sample and create a revised age-correction for the Danish pediatric population.
Methods:
The administration of EpiTrack Junior requires between 12 and 15 min. It is administrated individually and consists of six subtests derived from the adult version. A total of 346 healthy controls was examined using EpiTrack Junior. The controls were aged six to eighteen years.
Results:
The Danish norm sample observed a significantly higher proportion of EpiTrack Junior scores in the categories "mildy impaired" and "significantly impaired" relative to the norm sample from the German validation study. Our results indicate that in younger children (≤12 years) there is a decline in EpiTrack Junior score as this subgroup increases in age, while the EpiTrack Junior score of older children (≥13 years) does not change with age. As a result of these findings, we provide a suggestion for a revised age-correction for the Danish pediatric population.
Conclusion:
The Danish norm sample showed significantly lower test scores compared to the German control group, suggesting that a norm dataset is required to adapt the EpiTrack Junior test to different populations.
Related Concept Videos
01:29Drug Dosing: Infants and Children
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration